BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16489662)

  • 1. Progress in treatment of massive ascites and hepatorenal syndrome.
    Gerbes AL; Gulberg V
    World J Gastroenterol; 2006 Jan; 12(4):516-9. PubMed ID: 16489662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of refractory ascites and hepatorenal syndrome.
    Chutaputti A
    J Gastroenterol Hepatol; 2002 Apr; 17(4):456-61. PubMed ID: 11982727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and therapy of ascites in liver cirrhosis.
    Biecker E
    World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatorenal syndrome].
    Baccaro ME; Guevara M
    Gastroenterol Hepatol; 2007 Nov; 30(9):548-54. PubMed ID: 17980134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Hsu SJ; Huang HC
    J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical recommendations for the treatment of ascites and its complications.
    Bataller R; Ginès P; Arroyo V
    Drugs; 1997 Oct; 54(4):571-80. PubMed ID: 9339961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN; Boyer TD
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
    World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.